FDA’s vaccine advisers meet to decide whether Americans need boosters

Sep 17, 2021, 7:13 AM
vaccine mandate...
A nurse reaches for a vial of Pfizer-BioNTech Covid-19 vaccine at a pop up vaccine clinic in the Arleta neighborhood of Los Angeles, California, August 23, 2021. (Photo by Robyn Beck / AFP) (Photo by ROBYN BECK/AFP via Getty Images)
(Photo by ROBYN BECK/AFP via Getty Images)

    (CNN) — Vaccine advisers to the US Food and Drug Administration started meeting Friday morning to discuss whether many Americans need to start getting booster doses of coronavirus vaccine.

The all-day meeting will be packed with presentations. They’ll include Pfizer/BioNTech, which is arguing that there’s enough evidence of waning immunity to justify giving booster doses to people. The FDA will present its own take on the data that’s been sent to the agency so far — although written briefing materials published before the meeting suggest the agency is remaining neutral for the time being.

The Vaccines and Related Biological Products Advisory Committee is made up of vaccine experts, immunologists, pediatricians, infectious disease specialists and public health experts.

They’ll hear first from Dr. Peter Marks, who heads the FDA’s vaccine arm, the Center for Biologics Evaluation and Research. Another CBER official, Marion Gruber, will lay out the question at hand. It’s a routine presentation, but Gruber announced her retirement only a few weeks ago amid speculation that she was stepping down to protest White House involvement in the booster decision.

Gruber also, very unusually, signed a Lancet paper published earlier this week that argued it’s too soon to start giving people boosters.

Experts at the US Centers for Disease Control and Prevention will detail what’s known about how the Delta variant affects the rate of breakthrough infections. Researchers from the UK and Israel will present some real-world data about how many fully vaccinated people have become infected anyway, and whether giving boosters has lowered that rate of breakthroughs.

The meeting, which will be streamed online, is expected to last until 4:45 p.m. ET or later, with a period for discussion and vote scheduled to start at 2:25 p.m. and to last at least two hours.

Pfizer received full approval for its vaccine from the FDA, so the request to add a booster dose is a supplement to that approval. The data being presented by Pfizer involves a booster given to its volunteers about six months after they finished their first two doses.

Pfizer — and other researchers — say their studies show people develop strong immunity after two doses of vaccine, but that levels of antibodies start to drop after a few months.

“Concerns have been raised that declining neutralizing antibody titers or reduced effectiveness against symptomatic disease may herald significant declines in effectiveness against severe disease,” the FDA says in its briefing document.

“The recent emergence of the highly transmissible Delta variant of SARS-CoV-2 resulted in a new wave of COVID-19 cases in many parts of the world and has led to considerations for administration of booster doses to individuals who received primary series of vaccines in an effort to enhance immunity, and thus sustain protection from COVID-19. The expected benefit of booster vaccination will depend on the impact that booster vaccination has in reducing disease relative to the primary series.”

The FDA notes that Pfizer’s vaccine — as well as vaccines made by Moderna and Johnson & Johnson — still provide strong protection against severe disease, hospitalization and death, even if antibodies do wane over time.

FDA asked Pfizer to do more analysis of new Covid-19 cases diagnosed in July and August, when the Delta variant became dominant and after vaccinated people’s immunity could have been expected to have waned. The analysis showed the incidence of infection among people fully vaccinated 10 months before was 70.3 cases per 1,000 person-years, compared with 51.6 cases per 1,000 person-years among people who had been vaccinated five months before.

But there were only three cases of severe disease.

Pfizer argues this demonstrates waning immunity. “As the Delta variant has become widely disseminated, rates of COVID-19 are again on the rise in the United States and across the world,” the company says it its briefing document submitted to FDA.

“Although unvaccinated individuals continue to account for most SARS-CoV-2 infections and severe cases of COVID-19, real-world data suggest that rates of breakthrough infections may be on the rise and that vaccine effectiveness may be waning over time.”

The question will be whether it’s time to start approving boosters now and if so, who should get them and when.

The White House has said it’s planning to be ready to start giving booster doses of vaccines September 20, pending signoff from the FDA and CDC.

The CDC has scheduled a meeting of its vaccine advisers for September 22 and 23 — and CDC must give its stamp of approval for any booster doses to be officially given. ‘

Third doses are already approved for certain immunocompromised people, but not for the general public.

™ & © 2021 Cable News Network, Inc., a WarnerMedia Company. All rights reserved.

Today’s Top Stories

All News

garland unseal Trump...
Tierney Sneed, CNN

Merrick Garland says FBI files motion to unseal Trump Mar-a-Lago warrant

The move comes after days of silence from the Justice Department regarding the search, as is the department's practice for ongoing investigations.
16 hours ago
A Utah lawmaker is considering proposing an amendment to the state's constitution if the trigger la...
Simone Seikaly

Utah Attorney General asks for permission to appeal trigger law injunction

The injunction bars enforcement of SB 174, Utah's abortion "trigger law" until a lawsuit in district court is resolved.
16 hours ago
By Evan Perez, Gabby Orr and Pamela Brown, CNN

Feds removed documents from Mar-a-Lago in June with grand jury subpoena

(CNN) — The FBI search at Mar-a-Lago this week came months after federal investigators served an earlier grand jury subpoena and took away sensitive national security documents from former President Donald Trump’s property during a June meeting, people familiar with the matter tell CNN. Investigators executed Monday’s search in part because they had developed evidence, […]
16 hours ago
The Canyons School District is pictured. Its starting the year with a teacher shortage...
Adam Small

Canyons School District starting the year with a teacher and staff shortage

Canyons School District will start of the school year with a teacher and staff shortage. The district has over 150 openings.
16 hours ago
A lightning strike is pictured....
Samantha Herrera

Two Tooele houses struck by lightning in yesterday’s storm

TOOELE, Utah — Two houses were struck by lightning Wednesday night during a thunderstorm. Officials said there were no injuries, but some damage. Deputy Fire Chief Jed Colovich from the Tooele City Fire Department said one house had damage to its electrical outlets. The other house had damage to its sprinkler timer. Colovich said the […]
16 hours ago
draper shooting...
Kira Hoffelmeyer

One man dead after shooting in Draper early Thursday morning

The suspect is still at large after a shooting in Draper, and one man is dead after being shot with a gun. Police are still investigating.
16 hours ago

Sponsored Articles

FDA’s vaccine advisers meet to decide whether Americans need boosters